Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
November 23, 2006
[Quality of life: attitudes and perspectives of doctors in a thoracic oncology regional care network]
F Barlési, C Tchouhadjian, C Doddoli, et al.
British Journal of Cancer
|
December 15, 2004
CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
F Barlési, C Tchouhadjian, C Doddoli, et al.
Revue Des Maladies Respiratoires
|
May 24, 2007
[Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer]
C Tummino, F Barlesi, C Tchouhadjian, et al.
Revue Des Maladies Respiratoires
|
March 16, 2005
[Difficulties associated with Lambert-Eaton syndrome]
C Tchouhadjian, F Barlesi, C Doddoli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
November 23, 2006
[Quality of life: attitudes and perspectives of doctors in a thoracic oncology regional care network]
F Barlési, C Tchouhadjian, C Doddoli, et al.
British Journal of Cancer
|
December 15, 2004
CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
F Barlési, C Tchouhadjian, C Doddoli, et al.
Revue Des Maladies Respiratoires
|
May 24, 2007
[Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer]
C Tummino, F Barlesi, C Tchouhadjian, et al.
Revue Des Maladies Respiratoires
|
March 16, 2005
[Difficulties associated with Lambert-Eaton syndrome]
C Tchouhadjian, F Barlesi, C Doddoli, et al.
Page
of 1